Company Profiles

driven by the PitchBook Platform

Metamark Genetics

Description

Developer of prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. The company's tests will evaluate the genetic profile of an individual patient’s tumor and determine the expression of Metamark’s proprietary Prognosis Determinants. Based on data generated through clinical validation studies, individual tumors will be analyzed to determine the individual patient’s risk of recurrence, which will enable the patient and his or her physician to develop an individualized treatment plan.

2007

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$13M

Latest Deal Amount

$48M

Total Amount Raised

Description

Developer of prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. The company's tests will evaluate the genetic profile of an individual patient’s tumor and determine the expression of Metamark’s proprietary Prognosis Determinants. Based on data generated through clinical validation studies, individual tumors will be analyzed to determine the individual patient’s risk of recurrence, which will enable the patient and his or her physician to develop an individualized treatment plan.

Website:

www.metamarkgenetics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Primary Office

245 First Street 10th Floor Cambridge, MA 02142United States +1 (617) 583-1400
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Metamark Genetics's full profile, request a free trial.

Metamark Genetics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Metamark Genetics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Metamark Genetics Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Chione InvestmentsCorporationMinority000 0000000 0000
Chione Investments Corporation

Metamark Genetics Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Peter MaimonisChief Scientific Officer & Senior Vice President, Research & Development
David Rimm Ph.DConsultant & Co-Founder
Jerry WilliamsonSenior Vice President & Chief Commercial Officer
Kenneth WegCo-Founder, President, Chief Executive Officer & Chairman
Lynda Chin MDScientific Founder
Peter Maimonis Chief Scientific Officer & Senior Vice President, Research & Development
David Rimm Ph.D Consultant & Co-Founder
Jerry Williamson Senior Vice President & Chief Commercial Officer
Kenneth Weg Co-Founder, President, Chief Executive Officer & Chairman
Lynda Chin MD Scientific Founder

Metamark Genetics Board Members (6)

NameRepresentingRoleSinceContact
Info
Gregory Critchfield MDSelfBoard Member000 0000
Kenneth WegMetamark GeneticsCo-Founder, President, Chief Executive Officer & Chairman000 0000
Mansoor Mirza MDSelfBoard Member000 0000
Michael Kauffman Ph.DSelfBoard Member000 0000
Norman SelbySelfBoard Member000 0000
Gregory Critchfield MD Board Member Self
Kenneth Weg Co-Founder, President, Chief Executive Officer & Chairman Metamark Genetics
Mansoor Mirza MD Board Member Self
Michael Kauffman Ph.D Board Member Self
Norman Selby Board Member Self
Request full access to PitchBook